U.S., Feb. 4 -- An application to own the trademark for 'QUELIMMUNE' has been filed on Feb. 19, 2024.
Owner(s):
SeaStar Medical, Inc.; 3513 Brighton Boulevard, Suite 410, , Colorado
Goods and/or Services:
For: Selective cytopheretic devices, namely medical devices used to treat conditions caused by a dysregulated immune response by selectively binding certain activated white blood cells, reducing their inflammatory state, and releasing the modified blood cells back into the blood.
Class(es): 026, 039, 044
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https://eog-tmng.uspto.gov/#/issueDate=2025-01-21&serialNumber=98411109
Disclaimer: Curated by HT Syndication....